Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Colorectal Neoplasms 22Rectal Neoplasms 10Colonic Neoplasms 10Stomach Neoplasms 8Adenocarcinoma Of Esophagus 8Pancreatic Neoplasms 7Esophageal Neoplasms 7Adenocarcinoma 6Lymphoma, Large B-Cell, Diffuse 5Cholangiocarcinoma 5Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Neoplasms 3Gallbladder Neoplasms 3Endometrial Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Carcinoma 3Biliary Tract Neoplasms 3Ovarian Neoplasms 2Lymphoma, Non-Hodgkin 2Lymphoma, Follicular 2Lung Neoplasms 2Esophageal Squamous Cell Carcinoma 2Advanced Solid Tumors 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1Small Bowel Adenocarcinoma 1Recurrence 1

Interventions

Injections 5pembrolizumab 4Pemetrexed 3Carboplatin 3Oxaliplatin 2Leucovorin 2Fluorouracil 2trifluridine tipiracil drug combination 1tislelizumab 1sotorasib 1fludarabine 1WW Domain-Containing Oxidoreductase 1Panitumumab 1Paclitaxel 1Irinotecan 1Immune Checkpoint Inhibitors 1Drug Therapy 1Docetaxel 1Cetuximab 1Bevacizumab 1ASP1570 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Advanced Solid Tumors × Oxaliplatin × 30 days × Clear all
NCT05067283 2026-05-26

KANDLELIT-001

Merck Sharp & Dohme LLC

Phase 1 Recruiting
830 enrolled
Other solid neoplasm

Advanced Solid Tumors

NCT05083481 2026-05-05

A Study of ASP1570 Taken by Itself, or ASP1570 Taken Together With Either Pembrolizumab, Standard Therapies, or Both, in Adults With Solid Tumors

Astellas Pharma Inc

Phase 1/2 Active not recruiting
226 enrolled
Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡